ZA957877B - 17-deoxycorticosteroid-21-/O/-carboxylic esters processes for their preparation and pharmaceuticals containing these compounds - Google Patents

17-deoxycorticosteroid-21-/O/-carboxylic esters processes for their preparation and pharmaceuticals containing these compounds

Info

Publication number
ZA957877B
ZA957877B ZA957877A ZA957877A ZA957877B ZA 957877 B ZA957877 B ZA 957877B ZA 957877 A ZA957877 A ZA 957877A ZA 957877 A ZA957877 A ZA 957877A ZA 957877 B ZA957877 B ZA 957877B
Authority
ZA
South Africa
Prior art keywords
opt
deoxycorticosteroid
compounds
preparation
carboxylic esters
Prior art date
Application number
ZA957877A
Other languages
English (en)
Inventor
Ulrich Stache
Hans-Georg Alpermann
Manfred Bohn
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA957877B publication Critical patent/ZA957877B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA957877A 1994-09-20 1995-09-19 17-deoxycorticosteroid-21-/O/-carboxylic esters processes for their preparation and pharmaceuticals containing these compounds ZA957877B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4433374A DE4433374A1 (de) 1994-09-20 1994-09-20 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ZA957877B true ZA957877B (en) 1996-04-03

Family

ID=6528610

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957877A ZA957877B (en) 1994-09-20 1995-09-19 17-deoxycorticosteroid-21-/O/-carboxylic esters processes for their preparation and pharmaceuticals containing these compounds

Country Status (24)

Country Link
US (1) US5824670A (fr)
EP (1) EP0708111B1 (fr)
JP (1) JP3902255B2 (fr)
KR (1) KR100406627B1 (fr)
CN (1) CN1056151C (fr)
AT (1) ATE188480T1 (fr)
AU (1) AU695710B2 (fr)
CA (1) CA2158610C (fr)
CZ (1) CZ288297B6 (fr)
DE (2) DE4433374A1 (fr)
DK (1) DK0708111T3 (fr)
ES (1) ES2140596T3 (fr)
FI (1) FI114708B (fr)
GR (1) GR3032688T3 (fr)
HU (1) HU217438B (fr)
IL (1) IL115331A (fr)
NO (1) NO305210B1 (fr)
NZ (1) NZ280038A (fr)
PL (1) PL186071B1 (fr)
PT (1) PT708111E (fr)
RU (1) RU2161624C2 (fr)
SI (1) SI9500295B (fr)
TW (1) TW424094B (fr)
ZA (1) ZA957877B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012011106A1 (fr) * 2010-07-20 2012-01-26 Taro Pharmaceutical Industries Ltd. Procédé de préparation de 17-désoxy-corticostéroïdes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2755292A (en) * 1952-01-21 1956-07-17 Organon Labor Ltd Phenyl propionate of testosterone
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones
ES229413A1 (es) * 1956-06-22 1956-11-01 Francisco Vismara S P A UN PROCEDIMIENTO PARA LA PREPARACIoN DE COMPUESTOS ESTEROIDALES QUE CONTENGAN UN GRUPO CEToLICO EN LA CADENA LATERAL
DE1131668B (de) * 1959-07-16 1962-06-20 Leo Ab Verfahren zur Herstellung von Estern von Corticosteroid-Hormonen
CH495969A (de) * 1965-11-09 1970-09-15 Schering Ag Verfahren zur Herstellung neuer 21-Ester von 16a-Methyl-21-hydroxy- 1,4-steroiden
DE2047105C3 (de) * 1970-09-18 1979-02-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 17-Chlorsteroide und Verfahren zu ihrer Herstellung
US3956349A (en) * 1975-02-18 1976-05-11 Syntex (U.S.A.) Inc. Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
DE2617655C2 (de) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
LU77457A1 (fr) * 1977-05-31 1979-01-19
US4377573A (en) * 1978-01-06 1983-03-22 Leveen Harry H Method of control of gastrointestinal bleeding
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE2920726A1 (de) * 1979-05-18 1980-11-27 Schering Ag Neue kortikoide, ihre herstellung und verwendung
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE8303031D0 (sv) * 1983-05-30 1983-05-30 Leo Ab Improved steroid esters preparation
US4920114A (en) * 1988-06-28 1990-04-24 Merrell Dow Pharmaceuticals Inc. 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
NZ237559A (en) * 1990-04-02 1993-04-28 Merrell Dow Pharma Halogenoethyl steroid derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
KR960010681A (ko) 1996-04-20
ES2140596T3 (es) 2000-03-01
KR100406627B1 (ko) 2004-02-19
AU3172895A (en) 1996-04-04
RU2161624C2 (ru) 2001-01-10
DE4433374A1 (de) 1996-03-21
PL186071B1 (pl) 2003-10-31
SI9500295A (en) 1996-04-30
CA2158610C (fr) 2007-07-17
FI954394A0 (fi) 1995-09-18
CZ288297B6 (en) 2001-05-16
IL115331A (en) 2002-07-25
GR3032688T3 (en) 2000-06-30
JPH0899992A (ja) 1996-04-16
IL115331A0 (en) 1995-12-31
NO305210B1 (no) 1999-04-19
JP3902255B2 (ja) 2007-04-04
ATE188480T1 (de) 2000-01-15
CN1056151C (zh) 2000-09-06
PT708111E (pt) 2000-04-28
HU217438B (hu) 2000-01-28
CA2158610A1 (fr) 1996-03-21
FI114708B (fi) 2004-12-15
CN1124250A (zh) 1996-06-12
NO953695D0 (no) 1995-09-19
NO953695L (no) 1996-03-21
HUT72969A (en) 1996-06-28
FI954394A (fi) 1996-03-21
SI9500295B (en) 2001-12-31
US5824670A (en) 1998-10-20
DK0708111T3 (da) 2000-06-13
HU9502735D0 (en) 1995-11-28
DE59507565D1 (de) 2000-02-10
PL310544A1 (en) 1996-04-01
EP0708111B1 (fr) 2000-01-05
NZ280038A (en) 1997-03-24
AU695710B2 (en) 1998-08-20
TW424094B (en) 2001-03-01
CZ242595A3 (en) 1996-04-17
EP0708111A1 (fr) 1996-04-24

Similar Documents

Publication Publication Date Title
IE842524L (en) Cephalosporins and analogous carboxyalkenoic acid¹derivatives
FI933857A0 (fi) Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning
GR3031365T3 (en) Optically active pyridonecarboxylic acid derivatives
ATE51231T1 (de) Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel.
ATE121739T1 (de) Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung.
IE821768L (en) Pyrrolidine derivatives
AU4872793A (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA957877B (en) 17-deoxycorticosteroid-21-/O/-carboxylic esters processes for their preparation and pharmaceuticals containing these compounds
DE69411616D1 (de) Triazolopyridazin-Derivate, ihre Herstellung und Verwendung
ATE53209T1 (de) Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.
EP0461574A3 (en) Medicines containing 3,7-diazabicyclo(3,3,1)nonanes
ES8607963A1 (es) "un procedimiento para la preparacion de derivados de imi- dazol triciclicos"
ZA905650B (en) Method of treating diabetes mellitus
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
GB8728314D0 (en) New compositions of matter
EP0356765A3 (fr) Dérivés d'acide carboxylique, leur préparation et application
PT75981A (en) Process for the preparation of n,n-dissubstituted alkenamides and phenyl alkenamides
GR3000593T3 (en) Azaanthracene compounds
DE59105961D1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.